Skip to main content
. Author manuscript; available in PMC: 2013 Sep 21.
Published in final edited form as: Oncogene. 2012 May 14;32(12):1570–1579. doi: 10.1038/onc.2012.167

Figure 6. miR-502 was down-regulated in CRC clinical samples.

Figure 6

Twenty-three pairs of tumor and normal tissue from CRC patients were used, and miR-502 and Rab1B levels were quantified by real-time qRT-PCR and normalized to the internal control RNU44 and GAPDH respectively. The miR-502 and Rab1B levels in tumor tissues were compared to corresponding normal tissues.

HHS Vulnerability Disclosure